Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence

CompletedOBSERVATIONAL
Enrollment

7,000

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

March 31, 2024

Study Completion Date

April 1, 2024

Conditions
Cholera
Trial Locations (2)

Unknown

Epicentre/Médecins Sans Frontières, Bukama

Médecins Sans Frontières France, Goma

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

Institut National de Recherche Biomédicale. Goma, République Démocratique du Congo

UNKNOWN

collaborator

Ministry of Public Health, Democratic Republic of the Congo

OTHER_GOV

collaborator

Medecins Sans Frontieres, France

UNKNOWN

lead

Epicentre

OTHER

NCT05829772 - Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence | Biotech Hunter | Biotech Hunter